中国医院用药评价与分析2024，Vol.24Issue(11)：1336-1339,1343,5.DOI:10.14009/j.issn.1672-2124.2024.11.010
医疗机构拳参、南沙参饮片质量现状及改进措施思考
Quality Status and Improvement Measures of Decoction Pieces of Bistortae Rhizoma and Adenophprae Ae Radix in Medical Institutions
摘要
Abstract
OBJECTIVE:To explore the status,problems and improvement measures of quality of traditional Chinese medicine decoction pieces in medical institutions based on quality assessment of decoction pieces of Bistortae Rhizoma and Adenophprae Ae Radix,so as to provide reference for the quality improvement of traditional Chinese medicine decoction pieces in medical institutions.METHODS:Based on on-site sampling,scoring by expert blind review and statistical analysis,decoction pieces of Bistortae Rhizoma and Adenophprae Ae Radix were analyzed.RESULTS:Totally 49 samples of Bistortae Rhizoma and 50 samples of Adenophprae Ae Radix were drawn from 79 medical institutions,and the utilization rates of medical institutions were 62.03%and 63.29%,respectively.Among the samples of Bistortae Rhizoma,24 samples were rated as"good"(48.98%),4 samples were"medium"(8.16%),and 21 samples were"general"(42.86%).Of the samples of Adenophprae Ae Radix,11 samples were rated as"good"(22.00%),33 samples were"medium"(66.00%)and 6 samples were"general"(12.00%).CONCLUSIONS:The quality of decoction pieces in medical institutions needs to be improved.The two kinds of decoction pieces have species confusion.Medical institutions should pay attention to the quality evaluation and management of traditional Chinese medicine decoction pieces,improve the identification ability of traditional Chinese medicine personnel,and actively understand the development direction.At the national level,the construction and intensity of standards,systems and supervision should be strengthened.关键词
拳参/南沙参/中药饮片/医疗机构/质量管理Key words
Bistortae Rhizoma/Adenophprae Ae Radix/Traditional Chinese medicine decoction pieces/Medical institutions/Quality management分类
医药卫生引用本文复制引用
王琚丽,郭桂明,马春,李京生,李璐瑒,石敬依,赵奎君..医疗机构拳参、南沙参饮片质量现状及改进措施思考[J].中国医院用药评价与分析,2024,24(11):1336-1339,1343,5.基金项目
第六批北京市级中医药专家学术经验继承工作资助项目 （）
北京市第三批中药骨干人才培养项目 （）
北京市延庆区科学技术协会金桥工程种子资金项目 （）
